Stocks
Enochian Biosciences, Inc.ENOB
NASDAQHealthcareBiotechnology$0.71+1.79%
A clinical-stage biotechnology company focused on developing gene‑modified cell and immune therapies aimed at treating infectious diseases and certain cancers, including HIV and hepatitis B. The firm’s pipeline is based on engineered cell technologies designed to provide long‑term viral control or f...
Market Cap: $45.4M52W Range: $0.39 – $2.99
Congressional Interest in Enochian Biosciences, Inc. (ENOB)
1 member of Congress has disclosed 2 trades in Enochian Biosciences, Inc. (ENOB), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading ENOB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-11-08 | Christopher L. Jacobs | sell | $1K – $15K |
| 2022-07-18 | Christopher L. Jacobs | buy | $1K – $15K |